Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Jan;40(1):140–143. doi: 10.1172/JCI104227

EFFECTS OF PRIMAQUINE ON THE RED BLOOD CELL MEMBRANE. II. K+ PERMEABILITY IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENT ERYTHROCYTES*

Robert I Weed 1,2,
PMCID: PMC290698  PMID: 13783700

Full text

PDF
140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEUTLER E., DERN R. J., ALVING A. S. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med. 1954 Aug;44(2):177–184. [PubMed] [Google Scholar]
  2. BEUTLER E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957 Jan;49(1):84–95. [PubMed] [Google Scholar]
  3. BRODIE B. B., UDENFRIEND S. Metabolites of pamaquine in urine. Proc Soc Exp Biol Med. 1950 Aug;74(4):845–848. doi: 10.3181/00379727-74-18065. [DOI] [PubMed] [Google Scholar]
  4. DESFORGES J. F., KALAW E., GILCHRIST P. Inhibition of glucose-6-phosphate dehydrogenase by hemolysis inducing drugs. J Lab Clin Med. 1960 May;55:757–766. [PubMed] [Google Scholar]
  5. Feldman H. A., Packer H., Murphy F. D., Watson R. B. PAMAQUINE NAPHTHOATE AS A PROPHYLACTIC FOR MALARIAL INFECTIONS. J Clin Invest. 1947 Jan;26(1):77–86. doi: 10.1172/JCI101792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. PONDER E. Anomalous features of the loss of K from human red cells; results of extended observations. J Gen Physiol. 1951 Jan;34(3):359–372. doi: 10.1085/jgp.34.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. WEED R., EBER J., ROTHSTEIN A. Effects of Primaquine and other related compounds on the red blood cell membrane. I. Sodium ion and potassium ion permeability in normal human cells. J Clin Invest. 1961 Jan;40:130–139. doi: 10.1172/JCI104226. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES